Literature DB >> 18411429

Breast-cancer stromal cells with TP53 mutations.

Gérard Zalcman, Emmanuel Bergot, Pierre Hainaut.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18411429

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Mutations in bone marrow-derived stromal stem cells unmask latent malignancy.

Authors:  JeanMarie Houghton; Hanchen Li; Xueli Fan; Yingwang Liu; Jian Hua Liu; Varada P Rao; Theofilos Poutahidis; Christie L Taylor; Erin A Jackson; Christine Hewes; Stephen Lyle; Anna Cerny; Glennice Bowen; Jan Cerny; Nathan Moore; Evelyn A Kurt-Jones; Susan E Erdman
Journal:  Stem Cells Dev       Date:  2010-08       Impact factor: 3.272

2.  Cytogenetic abnormalities of tumor-associated endothelial cells in human malignant tumors.

Authors:  Tomoshige Akino; Kyoko Hida; Yasuhiro Hida; Kunihiko Tsuchiya; Deborah Freedman; Chikara Muraki; Noritaka Ohga; Kouhei Matsuda; Kousuke Akiyama; Toru Harabayashi; Nobuo Shinohara; Katsuya Nonomura; Michael Klagsbrun; Masanobu Shindoh
Journal:  Am J Pathol       Date:  2009-10-29       Impact factor: 4.307

3.  Limited copy number-high resolution melting (LCN-HRM) enables the detection and identification by sequencing of low level mutations in cancer biopsies.

Authors:  Hongdo Do; Alexander Dobrovic
Journal:  Mol Cancer       Date:  2009-10-08       Impact factor: 27.401
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.